S&P 500, Nasdaq open at new highs on COVID-19 treatment hopes


Aug 24 (Reuters) - The S&P 500 and Nasdaq opened at record levels on Monday after the U.S. health regulator approved the emergency use of blood plasma in COVID-19 patients and on report the Trump administration may fast-track a vaccine candidate.

The S&P 500 .SPX opened higher by 20.93 points, or 0.62%, at 3,418.09. The Nasdaq Composite .IXIC gained 137.45 points, or 1.22%, to 11,449.25 at the opening bell.

The Dow Jones Industrial Average .DJI rose 147.25 points, or 0.53%, at the open to 28,077.58.

(Reporting by Medha Singh in Bengaluru; Editing by Sriraj Kalluvila)

((Medha.Singh@thomsonreuters.com; within U.S. +1646 223 8780, outside U.S. +91 80 6749 1130; Twitter: https://twitter.com/medhasinghs))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.